You have 9 free searches left this month | for more free features.

Condition

B-cell Acute Lymphoblastic Leukemia (1)

Chronic Myelogenous Leukemia (1)

Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis (1)

Hepatic Impairment (1)

Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL (1)

Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

Sponsor

Novartis Pharmaceuticals (2)

Marlise R. Luskin (1)

Collaborator

Novartis (1)

Intervention

abl001 (3)

abl001 + nilotinib (1)

abl001+dasatinib (1)

abl001+imatinib (1)

dasatinib (1)

prednisone (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

abl001

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting

Chronic Myelogenous Leukemia
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

ABL001
+3 more

Boston, Massachusetts
+18 more

Jan 19, 2023

B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

Recruiting

B-cell Acute Lymphoblastic Leukemia
+2 more

ABL001
+2 more

Chicago, Illinois
+5 more

Dec 27, 2021

Hepatic Impairment Trial in Miami, Orlando, Minneapolis (ABL001)

Completed

Hepatic Impairment

ABL001

Miami, Florida
+2 more

Dec 6, 2020